Jeffrey A. Ledbetter
80Patents
37h-index
44Co-inventors
88Inventor score
Filing activity: Oct 19, 1984 → Oct 22, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5500362A | Chimeric antibody with specificity to human B cell surface antigen | Chemistry; Metallurgy | 777 | Expired |
| US5844095A | CTLA4 Ig fusion proteins | Chemistry; Metallurgy | 219 | Expired |
| US5434131A | Chimeric CTLA4 receptor and methods for its use | Emerging Cross-Sectional Technologies | 194 | Expired |
| US6132992A | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell | Physics | 172 | Expired |
| US5977318A | CTLA4 receptor and uses thereof | Emerging Cross-Sectional Technologies | 151 | Expired |
| US5677180A | Chimeric antibody with specificity to human B cell surface antigen | Chemistry; Metallurgy | 131 | Expired |
| US5637481A | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell | Physics | 130 | Expired |
| US5580756A | B7IG fusion protein | Emerging Cross-Sectional Technologies | 130 | Expired |
| US5521288A | CD28IG fusion protein | Emerging Cross-Sectional Technologies | 118 | Expired |
| US5721108A | Chimeric antibody with specificity to human B cell surface antigen | Chemistry; Metallurgy | 113 | Expired |
| US8409577B2 | Single chain multivalent binding proteins with effector function | Chemistry; Metallurgy | 111 | Active |
| US5770197A | Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules | Emerging Cross-Sectional Technologies | 111 | Expired |
| US6120767A | Chimeric antibody with specificity to human B cell surface antigen | Chemistry; Metallurgy | 109 | Expired |
| US6010902A | Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity | Chemistry; Metallurgy | 102 | Expired |
| US5851795A | Soluble CTLA4 molecules and uses thereof | Emerging Cross-Sectional Technologies | 99 | Expired |
| US5885796A | CTLA4 receptor and uses thereof | Emerging Cross-Sectional Technologies | 98 | Expired |
| US5773253A | MYPPPY variants of CTL A4 and uses thereof | Chemistry; Metallurgy | 95 | Expired |
| US5916560A | Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith | Chemistry; Metallurgy | 91 | Expired |
| US7754208B2 | Binding domain-immunoglobulin fusion proteins | Chemistry; Metallurgy | 89 | Expired |
| US5968510A | CTLA4 receptor and uses thereof | Emerging Cross-Sectional Technologies | 88 | Expired |
| US6623940B1 | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell | Physics | 80 | Expired |
| US6090914A | CTLA4/CD28Ig hybrid fusion proteins and uses thereof | Chemistry; Metallurgy | 79 | Expired |
| US5709859A | Mixed specificity fusion proteins | Emerging Cross-Sectional Technologies | 75 | Expired |
| US6893625B1 | Chimeric antibody with specificity to human B cell surface antigen | Chemistry; Metallurgy | 66 | Expired |
| US5885579A | CTLA4 receptor and uses thereof | Emerging Cross-Sectional Technologies | 64 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.